GB0921803D0 - Drug composition and its use in therapy - Google Patents

Drug composition and its use in therapy

Info

Publication number
GB0921803D0
GB0921803D0 GBGB0921803.3A GB0921803A GB0921803D0 GB 0921803 D0 GB0921803 D0 GB 0921803D0 GB 0921803 A GB0921803 A GB 0921803A GB 0921803 D0 GB0921803 D0 GB 0921803D0
Authority
GB
United Kingdom
Prior art keywords
therapy
drug composition
drug
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0921803.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biocopea Ltd
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GBGB0921803.3A priority Critical patent/GB0921803D0/en
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of GB0921803D0 publication Critical patent/GB0921803D0/en
Priority to AU2010332495A priority patent/AU2010332495C1/en
Priority to PCT/GB2010/052086 priority patent/WO2011073647A1/en
Priority to NZ600267A priority patent/NZ600267A/en
Priority to UAA201208623A priority patent/UA105827C2/en
Priority to SG10201408374WA priority patent/SG10201408374WA/en
Priority to RU2012129675/15A priority patent/RU2012129675A/en
Priority to PE2012000814A priority patent/PE20121538A1/en
Priority to MX2012006624A priority patent/MX2012006624A/en
Priority to CN2010800570274A priority patent/CN102802625A/en
Priority to BR112012014159A priority patent/BR112012014159A8/en
Priority to JP2012543903A priority patent/JP2013513652A/en
Priority to CA2784215A priority patent/CA2784215A1/en
Priority to SG2012042495A priority patent/SG181603A1/en
Priority to EP10796123A priority patent/EP2512472A1/en
Priority to US13/446,217 priority patent/US20120252824A1/en
Priority to CO12098529A priority patent/CO6541638A2/en
Priority to ZA2012/04294A priority patent/ZA201204294B/en
Priority to ECSP12011969 priority patent/ECSP12011969A/en
Priority to IL220384A priority patent/IL220384A0/en
Priority to US14/287,014 priority patent/US9314465B2/en
Priority to US14/287,015 priority patent/US9308211B2/en
Priority to US14/287,017 priority patent/US10016437B2/en
Priority to US14/488,215 priority patent/US20150005325A1/en
Priority to US14/687,393 priority patent/US20150216869A1/en
Priority to JP2015189277A priority patent/JP6078605B2/en
Priority to US14/991,892 priority patent/US20160120899A1/en
Priority to US15/061,656 priority patent/US9700561B2/en
Priority to US15/063,465 priority patent/US9675618B2/en
Priority to US15/144,800 priority patent/US20160271197A1/en
Priority to US15/144,798 priority patent/US20160271136A1/en
Priority to US16/042,670 priority patent/US10420812B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
GBGB0921803.3A 2009-06-16 2009-12-14 Drug composition and its use in therapy Ceased GB0921803D0 (en)

Priority Applications (32)

Application Number Priority Date Filing Date Title
GBGB0921803.3A GB0921803D0 (en) 2009-12-14 2009-12-14 Drug composition and its use in therapy
EP10796123A EP2512472A1 (en) 2009-12-14 2010-12-14 Therapeutic combinations of theobromine and an antihistamine
RU2012129675/15A RU2012129675A (en) 2009-12-14 2010-12-14 THERAPEUTIC COMBINATIONS OF THEOBROMIN AND ANTIHISTAMINE
MX2012006624A MX2012006624A (en) 2009-12-14 2010-12-14 Therapeutic combinations of theobromine and an antihistamine.
NZ600267A NZ600267A (en) 2009-12-14 2010-12-14 Combined oral preparation of theobromine and a decongestant for cough therapy
UAA201208623A UA105827C2 (en) 2009-12-14 2010-12-14 Normal;heading 1;heading 2;heading 3;HERAPEUTIC COMBINATION OF THEOBROMINE AND AN ANTIHISTAMINE ACTING ON H1-RECEPTOR
SG10201408374WA SG10201408374WA (en) 2009-12-14 2010-12-14 Therapeutic Combinations Of Theobromine And An Antihistamine
AU2010332495A AU2010332495C1 (en) 2009-12-14 2010-12-14 Therapeutic combinations of theobromine and an antihistamine
PE2012000814A PE20121538A1 (en) 2009-12-14 2010-12-14 THERAPEUTIC COMBINATIONS OF THEOBROMINE AND AN ANTIHISTAMINE
PCT/GB2010/052086 WO2011073647A1 (en) 2009-12-14 2010-12-14 Therapeutic combinations of theobromine and an antihistamine
CN2010800570274A CN102802625A (en) 2009-12-14 2010-12-14 Therapeutic combinations of theobromine and an antihistamine
BR112012014159A BR112012014159A8 (en) 2009-12-14 2010-12-14 therapeutic combinations of theobromine and an antihistamine
JP2012543903A JP2013513652A (en) 2009-12-14 2010-12-14 A therapeutic combination of theobromine and antihistamines
CA2784215A CA2784215A1 (en) 2009-12-14 2010-12-14 Therapeutic combinations of theobromine and an antihistamine
SG2012042495A SG181603A1 (en) 2009-12-14 2010-12-14 Therapeutic combinations of theobromine and an antihistamine
US13/446,217 US20120252824A1 (en) 2009-06-16 2012-04-13 Drug Combinations and Uses in Treating a Coughing Condition
CO12098529A CO6541638A2 (en) 2009-12-14 2012-06-12 THERAPEUTIC COMBINATIONS OF THEOBROMINE AND AN ANTIHISTAMINE
ECSP12011969 ECSP12011969A (en) 2009-12-14 2012-06-12 THERAPEUTIC COMBINATIONS OF THEOBROMINE AND AN ANTIHISTAMINE
ZA2012/04294A ZA201204294B (en) 2009-12-14 2012-06-12 Therapeutic combinations of theobromine and an antihistamine
IL220384A IL220384A0 (en) 2009-12-14 2012-06-13 Therapeutic combinations of theobromine and an antihistamine
US14/287,014 US9314465B2 (en) 2009-06-16 2014-05-24 Drug combinations and uses in treating a coughing condition
US14/287,015 US9308211B2 (en) 2009-06-16 2014-05-24 Drug combinations and uses in treating a coughing condition
US14/287,017 US10016437B2 (en) 2009-06-16 2014-05-24 Drug combinations and uses in treating a coughing condition
US14/488,215 US20150005325A1 (en) 2009-06-16 2014-09-16 Drug Combinations and Uses in Treating a Coughing Condition
US14/687,393 US20150216869A1 (en) 2009-06-16 2015-04-15 Drug Combinations and Uses in Treating a Coughing Condition
JP2015189277A JP6078605B2 (en) 2009-12-14 2015-09-28 A therapeutic combination of theobromine and antihistamines
US14/991,892 US20160120899A1 (en) 2009-06-16 2016-01-08 Drug Combinations and Uses in Treating a Coughing Condition
US15/061,656 US9700561B2 (en) 2009-06-16 2016-03-04 Drug combinations and uses in treating a coughing condition
US15/063,465 US9675618B2 (en) 2009-06-16 2016-03-07 Drug combinations and uses in treating a coughing condition
US15/144,800 US20160271197A1 (en) 2009-06-16 2016-05-02 Drug Combinations and Uses in Treating a Coughing Condition
US15/144,798 US20160271136A1 (en) 2009-06-16 2016-05-02 Drug Combinations and Uses in Treating a Coughing Condition
US16/042,670 US10420812B2 (en) 2009-06-16 2018-07-23 Drug combinations and uses in treating a coughing condition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0921803.3A GB0921803D0 (en) 2009-12-14 2009-12-14 Drug composition and its use in therapy

Publications (1)

Publication Number Publication Date
GB0921803D0 true GB0921803D0 (en) 2010-01-27

Family

ID=41667043

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0921803.3A Ceased GB0921803D0 (en) 2009-06-16 2009-12-14 Drug composition and its use in therapy

Country Status (17)

Country Link
EP (1) EP2512472A1 (en)
JP (2) JP2013513652A (en)
CN (1) CN102802625A (en)
AU (1) AU2010332495C1 (en)
BR (1) BR112012014159A8 (en)
CA (1) CA2784215A1 (en)
CO (1) CO6541638A2 (en)
GB (1) GB0921803D0 (en)
IL (1) IL220384A0 (en)
MX (1) MX2012006624A (en)
NZ (1) NZ600267A (en)
PE (1) PE20121538A1 (en)
RU (1) RU2012129675A (en)
SG (2) SG181603A1 (en)
UA (1) UA105827C2 (en)
WO (1) WO2011073647A1 (en)
ZA (1) ZA201204294B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
CN103263533B (en) * 2013-05-31 2014-11-05 杨宏伟 Theobromine composition for treating cough and application and preparation thereof
CN104224819B (en) * 2014-09-18 2016-08-17 中山大学 A kind of naringin and levo-cetirizine hydrochloride pharmaceutical composition and preparation thereof
CN104188998A (en) * 2014-09-18 2014-12-10 中山大学 Naringin and fexofenadine hydrochloride drug composition and preparation thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0247709B1 (en) * 1986-04-17 1991-01-02 Alza Corporation Chlorpheniramine therapy
HUP9700654A2 (en) 1997-03-26 1999-09-28 Dezső Korbonits Antitussive compositions containing theobromine
JPH10316568A (en) * 1997-05-13 1998-12-02 Taisho Pharmaceut Co Ltd Pharmaceutical composition
JP2003012514A (en) * 2001-07-02 2003-01-15 Taisho Pharmaceut Co Ltd Medicament composition
JP2003128549A (en) * 2001-08-15 2003-05-08 Rohto Pharmaceut Co Ltd Composition applicable to mucous membrane
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
AR066016A1 (en) * 2007-04-11 2009-07-15 Alcon Res Ltd USE OF AN ALFA TNF INHIBITOR TOGETHER WITH AN ANTIHISTAMINE TO TREAT ALLERGIC RHINITIS AND ALLERGIC CONJUNCTIVITIS

Also Published As

Publication number Publication date
CO6541638A2 (en) 2012-10-16
EP2512472A1 (en) 2012-10-24
RU2012129675A (en) 2014-01-27
WO2011073647A1 (en) 2011-06-23
CA2784215A1 (en) 2011-06-23
AU2010332495C1 (en) 2016-02-11
MX2012006624A (en) 2012-10-05
BR112012014159A2 (en) 2017-08-29
AU2010332495A1 (en) 2012-06-21
CN102802625A (en) 2012-11-28
ZA201204294B (en) 2013-02-27
JP2013513652A (en) 2013-04-22
SG10201408374WA (en) 2015-01-29
IL220384A0 (en) 2012-08-30
BR112012014159A8 (en) 2017-12-26
UA105827C2 (en) 2014-06-25
JP2016040280A (en) 2016-03-24
SG181603A1 (en) 2012-07-30
PE20121538A1 (en) 2012-12-21
NZ600267A (en) 2013-07-26
AU2010332495B2 (en) 2015-01-22
JP6078605B2 (en) 2017-02-08

Similar Documents

Publication Publication Date Title
ZA201206062B (en) Aminotetraline derivatives,pharmaceutical compositions containing them,and their use in therapy
IL218169A (en) Quinazoline compounds and pharmaceutical compositions comprising same for use in therapy
IL214244A0 (en) Scriptaid isosteres and their use in therapy
GB0817207D0 (en) therapeutic apsac compounds and their use
ZA201201287B (en) Therapeutic aryl-amido-aryl compounds and their use
GB0921803D0 (en) Drug composition and its use in therapy
HK1168283A1 (en) Sorcs1-like agent for use in the treatment of insulin resistance and diseases related thereto sorcs1
IL219768A0 (en) Drug combination with thebromine and its use in therapy
GB2460178B (en) Depsipeptides and their therapeutic use
IL219769A0 (en) Drug combination with theromine and its use in therapy
GB2460181B (en) Depsipeptides and their therapeutic use
GB0921805D0 (en) Drug composition and its use in therapy
GB0910375D0 (en) Drug composition and its use in therapy
GB0905970D0 (en) Depsipeptides and their therapeutic use
GB2460180B (en) Depsipeptides and their therapeutic use
GB0909354D0 (en) Drug composition and its use in therapy
GB0918727D0 (en) Drug composition and its use in therapy
GB0918728D0 (en) Drug composition and its use in therapy
GB0919890D0 (en) Drug composition and its use in therapy
GB0909352D0 (en) Drug composition and its use in therapy
GB0921804D0 (en) Drug composition and its use in therapy
GB0909344D0 (en) Drug composition and its uses in therapy
GB0920267D0 (en) Drug combination and its use in therapy
GB201021425D0 (en) Drug composition and its use in therapy
GB201019971D0 (en) Drug composition and its use in therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)